PFIZER, INC.

PFE

Delayed - 09/25 04:10:00 pm
36.05USD	+0.81%

Prev.	35.7600
Open	35.5400
High	36.1500
Low	35.5200
Volume	19 791 158

2h ago	Johnson & Johnson, Nike, Illumina: Stocks That Defined the Week
5h ago	Johnson & Johnson COVID-19 vaccine produces strong immune response in early...
9h ago	Europe takes new action against Apple, Boeing’s 737 MAX flying soon?
11h ago	Pfizer : BIOQuebec - Domain Therapeutics enters into a new collaboration...

	Short Term	Mid-Term	Long Term
Trend	Bearish	Bullish	Neutral
Resistance	37,2	39,3	40,5
Spread/Res.	-3,1%	-8,2%	-11%
Spread/Supp.	1,7%	1,7%	24%
Support	35,5	35,5	29,0

Sales 2020	48 906 M - -
Net income 2020	13 460 M - -
Net Debt 2020	34 671 M - -
P/E ratio 2020	17,1x
Yield 2020	4,20%

Capitalization	200 B 200 B -
EV / Sales 2020	4,81x
EV / Sales 2021	4,11x
Nbr of Employees	88 300
Free-Float	59,1%

Pfizer, Inc. the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- biopharmaceuticals (76.2%): innovative drugs for the treatment of cancer, inflammatory, autoimmune, infectious, metabolic, cardiovascular and rare diseases, vaccines, etc. In addition,...

>> Read more

Sector :

Pharmaceuticals - NEC

Calendar :

2020-11-03 Earnings Release

Trading Rating :

Investor Rating :

Mean consensus	OUTPERFORM
Number of Analysts	18
Average target price	42,63 $
Last Close Price	36,05 $
Spread / Highest target	52,6%
Spread / Average Target	18,3%
Spread / Lowest Target	-2,91%